|Articles|December 1, 2019
- BioPharm International-12-01-2019
- Volume 32
- Issue 12
BioPharm International, December 2019 Issue (PDF)
Click the title above to open the BioPharm International December 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Building a Biopharma Companyabout 6 years ago
The Evolving Role of Starting Materials in Cell and Gene Therapyabout 6 years ago
Fighting the Good Fightabout 6 years ago
Prevent, Detect, and Remove: Viral Control for Viral Vectorsabout 6 years ago
Investigating Combination Product Failuresabout 6 years ago
Quality Issues Offset Biomedical Advancesabout 6 years ago
Antibody Purification Process Development and ManufacturingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5